Join to view full profile
3800 Park Nicollet BlvdMinneapolis, MN 55416
Dr. Matfin is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Arizona College of Medicine-PhoenixFellowship, Endocrinology, Diabetes, and Metabolism, 1996 - 1998
University of South Florida MorsaniResidency, Internal Medicine, 1995 - 1997
HCA Florida Healthcare/USF Morsani College of Medicine GME - Tampa North/Bayonet Point HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 1994 - 1995
University of Leeds School of MedicineClass of 1987
Certifications & Licensure
CA State Medical License 2023 - 2025
MN State Medical License 2012 - 2015
MA State Medical License 2003 - 2012
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2011
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2011
Publications & Presentations
PubMed
- 13 citationsClinical Characteristics and Outcomes of Patients With Diabetes Admitted for COVID-19 Treatment in Dubai: Single-Centre Cross-Sectional Study.Rahila Bhatti, Amar Hassan Khamis, Samara Khatib, Seemin Shiraz, Glenn Matfin
JMIR Public Health and Surveillance. 2020-12-07 - 40 citationsSafe and Effective Use of the Once Weekly Dulaglutide Single-Dose Pen in Injection-Naïve Patients With Type 2 Diabetes.Glenn Matfin, Kate Van Brunt, Alan G. Zimmermann, Rebecca Threlkeld, Debra A. Ignaut
Journal of Diabetes Science and Technology. 2015-04-21 - 213 citationsRecommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP).Richard M. Bergenstal, Andrew J. Ahmann, Timothy L. Bailey, Roy W. Beck, Joan Bissen
Diabetes Technology & Therapeutics. 2013-03-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
